Authors:
Fergusson, D
VanWalraven, C
Coyle, D
Laupacis, A
Citation: D. Fergusson et al., Economic evaluations of technologies to minimize perioperative transfusion: A systematic review of published studies, TR MED REV, 13(2), 1999, pp. 106-117
Citation: Jw. Smith et Ro. Gilcher, Red blood cells, plasma, and other new apheresis-derived blood products: Improving product quality and donor utilization, TR MED REV, 13(2), 1999, pp. 118-123
Citation: B. Larocque et al., The utility and prediction of allogeneic blood transfusion use in orthopedic surgery, TR MED REV, 13(2), 1999, pp. 124-131
Citation: Kmt. Mitchell et Me. Brecher, Approaches to the detection of bacterial contamination in cellular blood products, TR MED REV, 13(2), 1999, pp. 132-144
Authors:
Hillyer, CD
Lankford, KV
Roback, JD
Gillespie, TW
Silberstein, LE
Citation: Cd. Hillyer et al., Transfusion of the HIV-seropositive patient: Immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8, TR MED REV, 13(1), 1999, pp. 1-17
Citation: L. Corash, Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives, TR MED REV, 13(1), 1999, pp. 18-30
Citation: Lj. Dumont et al., Platelet surface P-selectin measurements in platelet preparations: An international collaborative study, TR MED REV, 13(1), 1999, pp. 31-42
Citation: Jkm. Duguid et Im. Bromilow, Laboratory measurement of fetomaternal hemorrhage and its clinical relevance, TR MED REV, 13(1), 1999, pp. 43-48
Citation: Ec. Vamvakas, METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF THE EFFICACY OF WHITECELL-REDUCTION IN PREVENTING HLA-ALLOIMMUNIZATION AND REFRACTORINESS TO RANDOM-DONOR PLATELET TRANSFUSIONS, Transfusion medicine reviews, 12(4), 1998, pp. 258-270
Citation: Hm. Rinder et Ka. Ault, PLATELET ACTIVATION AND ITS DETECTION DURING THE PREPARATION OF PLATELETS FOR TRANSFUSION, Transfusion medicine reviews, 12(4), 1998, pp. 271-287
Citation: S. Kleinman et Ae. Williams, DONOR SELECTION PROCEDURES - IS IT POSSIBLE TO IMPROVE THEM, Transfusion medicine reviews, 12(4), 1998, pp. 288-302
Citation: C. Faught et al., ADVERSE-EFFECTS OF METHODS FOR MINIMIZING PERIOPERATIVE ALLOGENEIC TRANSFUSION - A CRITICAL-REVIEW OF THE LITERATURE, Transfusion medicine reviews, 12(3), 1998, pp. 206-225
Citation: Kg. Hadlock et Skh. Foung, GBV-C HGV - A NEW VIRUS WITHIN THE FLAVIVIRIDAE AND ITS CLINICAL IMPLICATIONS/, Transfusion medicine reviews, 12(2), 1998, pp. 94-108
Citation: P. Morel et P. Herve, SURVEILLANCE OF BLOOD-TRANSFUSION SAFETY - CONTRIBUTION OF THE HEMOVIGILANCE STRATEGY IN FRANCE, Transfusion medicine reviews, 12(2), 1998, pp. 109-127